1. Home
  2. ONVO vs MITQ Comparison

ONVO vs MITQ Comparison

Compare ONVO & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONVO
  • MITQ
  • Stock Information
  • Founded
  • ONVO 2007
  • MITQ N/A
  • Country
  • ONVO United States
  • MITQ United States
  • Employees
  • ONVO N/A
  • MITQ N/A
  • Industry
  • ONVO Biotechnology: Biological Products (No Diagnostic Substances)
  • MITQ Telecommunications Equipment
  • Sector
  • ONVO Health Care
  • MITQ Telecommunications
  • Exchange
  • ONVO Nasdaq
  • MITQ Nasdaq
  • Market Cap
  • ONVO 7.2M
  • MITQ 6.0M
  • IPO Year
  • ONVO N/A
  • MITQ 2021
  • Fundamental
  • Price
  • ONVO $0.42
  • MITQ $0.59
  • Analyst Decision
  • ONVO
  • MITQ
  • Analyst Count
  • ONVO 0
  • MITQ 0
  • Target Price
  • ONVO N/A
  • MITQ N/A
  • AVG Volume (30 Days)
  • ONVO 102.4K
  • MITQ 67.8K
  • Earning Date
  • ONVO 11-26-2024
  • MITQ 11-14-2024
  • Dividend Yield
  • ONVO N/A
  • MITQ N/A
  • EPS Growth
  • ONVO N/A
  • MITQ N/A
  • EPS
  • ONVO N/A
  • MITQ N/A
  • Revenue
  • ONVO $103,000.00
  • MITQ $18,756,000.00
  • Revenue This Year
  • ONVO $59.08
  • MITQ N/A
  • Revenue Next Year
  • ONVO $18.24
  • MITQ N/A
  • P/E Ratio
  • ONVO N/A
  • MITQ N/A
  • Revenue Growth
  • ONVO N/A
  • MITQ N/A
  • 52 Week Low
  • ONVO $0.32
  • MITQ $0.42
  • 52 Week High
  • ONVO $1.74
  • MITQ $1.44
  • Technical
  • Relative Strength Index (RSI)
  • ONVO 47.62
  • MITQ 47.73
  • Support Level
  • ONVO $0.39
  • MITQ $0.58
  • Resistance Level
  • ONVO $0.46
  • MITQ $0.67
  • Average True Range (ATR)
  • ONVO 0.05
  • MITQ 0.04
  • MACD
  • ONVO -0.00
  • MITQ -0.00
  • Stochastic Oscillator
  • ONVO 62.27
  • MITQ 13.36

About ONVO Organovo Holdings Inc.

Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

Share on Social Networks: